Anne‐Grete Märtson

1.3k total citations · 1 hit paper
35 papers, 645 citations indexed

About

Anne‐Grete Märtson is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Anne‐Grete Märtson has authored 35 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 15 papers in Infectious Diseases and 12 papers in Pharmacology. Recurrent topics in Anne‐Grete Märtson's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Antifungal resistance and susceptibility (9 papers) and Herpesvirus Infections and Treatments (8 papers). Anne‐Grete Märtson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Antifungal resistance and susceptibility (9 papers) and Herpesvirus Infections and Treatments (8 papers). Anne‐Grete Märtson collaborates with scholars based in Netherlands, Australia and United Kingdom. Anne‐Grete Märtson's co-authors include Jan‐Willem C. Alffenaar, Sebastian G. Wicha, Lena E. Friberg, Birgit C. P. Koch, Elisabet I. Nielsen, Iris K. Minichmayr, Tjip S. van der Werf, Charles A. Peloquin, Marieke G. G. Sturkenboom and Daan J. Touw and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Anne‐Grete Märtson

32 papers receiving 638 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics

2021 180 citations Sebastian G. Wicha, Anne‐Grete Märtson et al. Clinical Pharmacology & Therapeutics profile →

Peers

Countries citing papers authored by Anne‐Grete Märtson

Since Specialization

Citations

This map shows the geographic impact of Anne‐Grete Märtson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Grete Märtson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Grete Märtson more than expected).

Fields of papers citing papers by Anne‐Grete Märtson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Grete Märtson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Grete Märtson. The network helps show where Anne‐Grete Märtson may publish in the future.

Co-authorship network of co-authors of Anne‐Grete Märtson

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Grete Märtson. A scholar is included among the top collaborators of Anne‐Grete Märtson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Grete Märtson. Anne‐Grete Märtson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Antagonistic interaction between posaconazole and olorofim in a murine model of invasive pulmonary aspergillosis 2025 ·Journal of Antimicrobial Chemotherapy ·(unknown), Nicola Farrington, Anne‐Grete Märtson, Adam Johnson, Laura McEntee, (unknown), Adam J. Stevenson, (unknown), (unknown), Shampa Das, William Hope	1
2	The pharmacokinetics of antibiotics in patients with obesity: a systematic review and consensus guidelines for dose adjustments 2025 ·The Lancet Infectious Diseases ·Anne‐Grete Märtson, Katie E. Barber, Ryan L. Crass, Maya Hites, Charlotte Kloft, Joseph L. Kuti, Elisabet I. Nielsen, Manjunath P. Pai, Markus Zeitlinger, Jason A. Roberts, Thomas Tängdén	1
3	Revisiting Acyclovir Dosing for Adult Viral Encephalitis Using a Full Bayesian LeiCNS PBPK Modeling Approach 2025 ·Clinical Pharmacokinetics ·(unknown), Martijn L. Manson, Anne‐Grete Märtson, Jacob Bodilsen, Elizabeth C. M. de Lange, Tingjie Guo	0
4	A systematic review of antibiotic drug shortages and the strategies employed for managing these shortages 2024 ·Clinical Microbiology and Infection ·Avaneesh Kumar Pandey, Jennifer Cohn, Vrinda Nampoothiri, U. Gadde, (unknown), Ashish Kumar Kakkar, Yogendra Kumar Gupta, Samir Malhotra, Oluchi Mbamalu, Marc Mendelson, Anne‐Grete Märtson, (unknown), Thomas Tängdén, Nusrat Shafiq, Esmita Charani	14
5	Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections 2024 ·Scientific Reports ·Richard Wilson, (unknown), (unknown), Damien Ming, (unknown), (unknown), Mark Gilchrist, Anne‐Grete Märtson, William Hope, Alison Holmes, Timothy M. Rawson	0
6	Exposure of anti-infective drugs and the dynamic changes of the gut microbiota during gastrointestinal mucositis in autologous stem cell transplant patients: a pilot study 2023 ·Annals of Hematology ·Anne‐Grete Märtson, (unknown), Anette Veringa, Lei Liu, Hannah R. Wardill, (unknown), Tjip S. van der Werf, Hermie J. M. Harmsen, Marieke G. G. Sturkenboom, Lambert F. R. Span, Wim J. E. Tissing, Jan‐Willem C. Alffenaar	2
7	Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review 2023 ·Drugs ·(unknown), Mattia Trunfio, Anne‐Grete Märtson, Filippo Lipani, Sabrina Audagnotto, Giovanni Di Perri, Andrea Calcagno	11
8	Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loop 2023 ·The Lancet Infectious Diseases ·Alex Howard, (unknown), Stephen Aston, Beth Woods, (unknown), Iain Buchan, William Hope, Anne‐Grete Märtson	3
9	Voriconazole exposure is influenced by inflammation: A population pharmacokinetic model 2023 ·International Journal of Antimicrobial Agents ·(unknown), Anne‐Grete Märtson, Anette Veringa, Nieko Punt, Tjip S. van der Werf, Jan‐Willem C. Alffenaar, Marieke G. G. Sturkenboom, Daan J. Touw	21
10	Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections 2021 ·Clinical Pharmacokinetics ·Jan‐Willem C. Alffenaar, Anne‐Grete Märtson, Scott K. Heysell, Jin‐Gun Cho, Asad E. Patanwala, (unknown), (unknown), Marieke G. G. Sturkenboom, Anthony Byrne, Debbie Marriott, Indy Sandaradura, Simon Tiberi, (unknown), Shashikant Srivastava, Charles A. Peloquin	29
11	From Therapeutic Drug Monitoring to Model‐Informed Precision Dosing for Antibiotics breakdown → 2021 ·Clinical Pharmacology & Therapeutics ·Sebastian G. Wicha, Anne‐Grete Märtson, Elisabet I. Nielsen, Birgit C. P. Koch, Lena E. Friberg, Jan‐Willem C. Alffenaar, Iris K. Minichmayr	180
12	Standard ganciclovir dosing results in slow decline of cytomegalovirus viral loads 2021 ·Journal of Antimicrobial Chemotherapy ·Anne‐Grete Märtson, Marieke G. G. Sturkenboom, Marjolein Knoester, Tjip S. van der Werf, Jan‐Willem C. Alffenaar, William Hope, (unknown), Johannes G. M. Burgerhof, Stefan P. Berger, (unknown), Kevin Damman, Erik A.M. Verschuuren, Hans Blokzijl, (unknown), Daan J. Touw, (unknown)	13
13	Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs 2021 ·Clinical Pharmacokinetics ·Marieke G. G. Sturkenboom, Anne‐Grete Märtson, Elin M. Svensson, Derek J. Sloan, Kelly E. Dooley, (unknown), Paolo Denti, Charles A. Peloquin, Rob E. Aarnoutse, Jan‐Willem C. Alffenaar	48
14	Precision Therapy for Invasive Fungal Diseases 2021 ·Journal of Fungi ·Anne‐Grete Märtson, Jan‐Willem C. Alffenaar, Roger J. M. Brüggemann, William Hope	6
15	Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems 2020 ·Expert Opinion on Drug Metabolism & Toxicology ·Anne‐Grete Märtson, Gena Burch, Samiksha Ghimire, Jan‐Willem C. Alffenaar, Charles A. Peloquin	43
16	Exploring failure of antimicrobial prophylaxis and pre-emptive therapy for transplant recipients: a systematic review 2020 ·BMJ Open ·Anne‐Grete Märtson, (unknown), Hans Blokzijl, Erik A.M. Verschuuren, Stefan P. Berger, Lambert F. R. Span, Tjip S. van der Werf, Jan‐Willem C. Alffenaar	2
17	Saliva for Precision Dosing of Antifungal Drugs: Saliva Population PK Model for Voriconazole Based on a Systematic Review. 2020 ·Frontiers in Pharmacology ·Hannah Yejin Kim, Anne‐Grete Märtson, Erwin Dreesen, Isabel Spriet, Sebastian G. Wicha, Andrew J. McLachlan, Jan‐Willem C. Alffenaar	14
18	How to design a study to evaluate therapeutic drug monitoring in infectious diseases? 2020 ·Clinical Microbiology and Infection ·Anne‐Grete Märtson, Marieke G. G. Sturkenboom, Jana Stojanova, Dario Cattaneo, William Hope, Deborah Marriott, Asad E. Patanwala, Charles A. Peloquin, Sebastian G. Wicha, Tjip S. van der Werf, Thomas Tängdén, Jason A. Roberts, Michael Neely, Jan‐Willem C. Alffenaar	30
19	Posaconazole trough concentrations are not influenced by inflammation: A prospective study 2019 ·International Journal of Antimicrobial Agents ·Anne‐Grete Märtson, Anette Veringa, (unknown), Edwin R. van den Heuvel, Daan J. Touw, Tjip S. van der Werf, Lambert F. R. Span, Jan‐Willem C. Alffenaar	11
20	Ganciclovir Therapeutic Drug Monitoring: A Case Series 2019 ·Therapeutic Drug Monitoring ·Anne‐Grete Märtson, Daan J. Touw, Kevin Damman, (unknown), Annemieke Oude Lansink‐Hartgring, Tjip S. van der Werf, Marjolein Knoester, Jan‐Willem C. Alffenaar	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact